Femasys Inc Quick Ratio (FEMY) starting from the second quarter 2026 to second quarter 2025, Financial Strength Trends, Rankings, Financial Ratios - CSIMarket
CSIMarket Company Name, Ticker, Suppliers, else..
 


• Quick Ratio
• Working Capital
• LT Debt to Equity
• Debt to Equity
• Leverage Ratio
• Tangible Leverage
• Interest Coverage
• Debt Coverage
• Work. Cap. Per Revenue
Femasys Inc   (NASDAQ: FEMY)

Femasys Inc 's Quick Ratio

FEMY's quarterly Quick Ratio and Cash & cash equivalent, Current Liabilities growth


In the wake of the increase in Current Liabilities in the second quarter 2026, Quick Ratio fell to 0.37 below Femasys Inc average.

Within Medical Equipment & Supplies industry 156 other companies have achieved higher Quick Ratio than Femasys Inc in second quarter 2026. While Quick Ratio total ranking in the second quarter 2026 has deteriorated compared to the prior quarter from 1351 to 1552.

Explain Quick Ratio?
How much Cash & cash equivalents FEMY´s has?
What are FEMY´s Current Liabilities?



Download as CSV
Commercial Data Licensing & OEM
Annual commercial subscriptions for corporate use, internal BI systems, management reporting, AI integration, and client-facing platforms
API & Data Feeds
Programmatic access to normalized fundamentals & ratios.

FEMY Quick Ratio (Jun 30 2026)
Q2		 (Mar 31 2026)
Q1		 (Dec 31 2025)
Q4		 (Sep 30 2025)
Q3		 (Jun 30 2025)
Q2
Y / Y Current Liabilities Change -64.55 % -67.94 % -63.93 % 368.62 % 496.54 %
Y / Y Cash & cash equivalent Change -55.14 % 40.99 % 168.45 % -39.97 % -76.21 %
Quick Ratio MRQ 0.37 1.71 2.99 0.43 0.29
FEMY's Total Ranking # 1552 # 1351 # 3229 # 3679 # 3421
Seq. Current Liabilities Change 23.19 % 1.92 % -70.63 % -3.85 % 11.41 %
Seq. Cash & cash equivalent Change -73.2 % -41.88 % 102.81 % 41.98 % -15.76 %



Quick Ratio second quarter 2026 Company Ranking
Within: No.
Medical Equipment & Supplies Industry # 157
Healthcare Sector # 765
Overall Market # 2894


Quick Ratio Statistics
High Average Low
19.65 7.8 0.29
(Sep 30 2021)   (Jun 30 2025)




Financial Statements
Femasys Inc 's Current Liabilities $ 4 Millions Visit FEMY's Balance sheet
Femasys Inc 's Cash & cash equivalent $ 1 Millions Visit FEMY's Balance sheet
Source of FEMY's Sales Visit FEMY's Sales by Geography


Cumulative Femasys Inc 's Quick Ratio

FEMY's Quick Ratio for the trailling 12 Months

FEMY Quick Ratio

 (Jun 30 2026)
12 Months		 (Mar 31 2026)
12 Months		 (Dec 31 2025)
12 Months		 (Sep 30 2025)
12 Months		 (Jun 30 2025)
12 Months
Y / Y Current Liabilities TTM Growth -34.63 % 23.3 % 138.53 % 373.17 % 300.78 %
Y / Y Cash & cash equivalent TTM Growth 14.16 % -21.01 % -50.8 % -75.19 % -70.7 %
Quick Ratio TTM 1 0.81 0.61 0.38 0.57
Total Ranking TTM # 1524 # 2100 # 1994 # 1653 # 1008
Seq. Current Liabilities TTM Growth -25.5 % -19.41 % -13.74 % 26.21 % 40.54 %
Seq. Cash & cash equivalent TTM Growth -7.91 % 7.5 % 38.61 % -16.81 % -36.28 %

Quick ratio ranking by company, industry and sector >> Back to FEMY Financial Strength Comparisons >> Go to Compare FEMY Quick Ratio to its Competitors

On the trailing twelve months basis Current Liabilities decreased faster than Femasys Inc 's average Cash & cash equivalent, this led to increase in in Femasys Inc 's Quick Ratio to 1, Quick Ratio remained below FEMY average.
Quick Ratio is the average cumulative value over the last four quarters.

Among companies operating within Medical Equipment & Supplies industry 201 other companies have achieved higher Quick Ratio than Femasys Inc . While Quick Ratio overall ranking has improved so far to 0, from total ranking during the twelve months ending first quarter 2026 at 3163.

Explain Quick Ratio?
How much Cash & cash equivalents FEMY´s has?
What are FEMY´s Current Liabilities?

TTM Quick Ratio Company Ranking
Within: No.
Within the Medical Equipment & Supplies Industry # 202
Healthcare Sector # 893
Within the Market # 1552


trailing twelve months Quick Ratio Statistics
High Average Low
13.89 6.07 0.38
(Mar 31 2022)   (Sep 30 2025)




Companies with similar Quick Ratio in the quarter ending Jun 30 2026, within Medical Equipment & Supplies Industry Quick RatioJun 30 2026 MRQ Cash & cash equivalentJun 30 2026 MRQ Current Liabilities
Plus Therapeutics Inc   1.00 $ 8.587  Millions$ 8.567  Millions
Pavmed Inc   1.00 $ 4.070  Millions$ 4.088  Millions
Sonoma Pharmaceuticals Inc   0.98 $ 5.338  Millions$ 5.447  Millions
Nuwellis Inc   0.98 $ 3.922  Millions$ 4.008  Millions
Electrocore Inc   0.97 $ 11.543  Millions$ 11.933  Millions
Qt Imaging Holdings Inc exact Name Of Registrant As Specified In Its Charter _______________________  0.96 $ 10.924  Millions$ 11.366  Millions
Medline Inc   0.96 $ 2,677.000  Millions$ 2,803.000  Millions
Neuronetics Inc   0.88 $ 24.947  Millions$ 28.309  Millions
Orthopediatrics Corp  0.87 $ 45.879  Millions$ 52.852  Millions
Haemonetics Corporation  0.85 $ 223.384  Millions$ 263.235  Millions
Lifeward ltd   0.85 $ 9.448  Millions$ 11.159  Millions
Qhslab Inc   0.84 $ 0.317  Millions$ 0.376  Millions
Intelligent Bio Solutions Inc   0.84 $ 4.141  Millions$ 4.935  Millions
Integra Lifesciences Holdings Corp  0.83 $ 274.084  Millions$ 330.881  Millions
Lifestance Health Group Inc   0.82 $ 225.943  Millions$ 274.753  Millions
Pro dex Inc   0.81 $ 10.542  Millions$ 13.086  Millions
Carlisle Companies Incorporated  0.75 $ 665.300  Millions$ 888.400  Millions
Northview Acquisition Corp  0.73 $ 12.200  Millions$ 16.622  Millions
Livanova Plc  0.73 $ 516.619  Millions$ 707.004  Millions
Angiodynamics Inc   0.72 $ 53.864  Millions$ 74.717  Millions
Rosecliff Acquisition Corp I  0.70 $ 14.000  Millions$ 19.869  Millions
Innovage Holding Corp   0.69 $ 141.326  Millions$ 203.891  Millions
Msa Safety Inc  0.69 $ 200.057  Millions$ 288.899  Millions
Valion Bio Inc   0.69 $ 2.108  Millions$ 3.046  Millions
Lensar Inc   0.69 $ 13.565  Millions$ 19.640  Millions
West Pharmaceutical Services Inc   0.68 $ 435.800  Millions$ 640.500  Millions
Nexalin Technology Inc   0.68 $ 1.005  Millions$ 1.485  Millions
Orthofix Medical Inc   0.66 $ 103.810  Millions$ 157.010  Millions
Privia Health Group Inc   0.65 $ 412.200  Millions$ 634.444  Millions
Positron Corporation  0.60 $ 1.357  Millions$ 2.252  Millions

Date modified: 2026-09-26T07:40:02+00:00



Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.